Evidence map›Paper›PMID 21907104›Full record

ReviewClinics in laboratory medicine2011

Peptide immunoaffinity enrichment coupled with mass spectrometry for peptide and protein quantification.

Jeffrey R Whiteaker, Amanda G Paulovich

Abstract readReview
In one paragraph

Review in Clinics in laboratory medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. The Breast Cancer Proteome and Precision Oncology.Cold Spring Harbor perspectives in medicine · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Clinical potential of mass spectrometry-based proteogenomics.Nature reviews. Clinical oncology · 2019
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jeffrey R WhiteakerFred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. jwhiteak@fhcrc.org
Amanda G Paulovich

Funding

Measuring Cancer Biomarker Candidates by Targeted MS and Ab EnrichmentU24CA126476 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI CARR, STEVEN A · 2006 to 2010
$14.6M
NCI NIH HHS U24 CA126476
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ImmunoassayAntibodiesHumansIsotope LabelingLimit of DetectionMass SpectrometryPeptidesPlasmaProteinsProteomicsTrypsinAntibodiesPeptidesProteinsTrypsin

Identifiers

PMID21907104
PMCPMC3186071

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.